Biology comes first. The vaginal and cervical lining is a larger and more delicate surface than the male urethra, which makes it easier for bacteria and viruses to take hold during sex. Microscopic tears that go unnoticed are common, especially without enough natural lubrication or when intercourse happens in haste.

Many STIs in women cause no symptoms for weeks or months. Chlamydia is the classic example — most infections in women are completely silent until the infection has already crept up to the uterus or fallopian tubes and started to cause pelvic inflammatory disease. By that point, the damage to fertility may already be underway.

Indian social patterns add a second layer. Married women are often infected by partners whose earlier exposures have never been discussed; premarital silence around sex means many young women do not know what protected sex looks like in practice; and the cultural belief that STIs only happen to 'a certain kind of woman' keeps many out of clinics until symptoms become impossible to ignore.

None of this is the patient's fault. STIs are infections, not character verdicts, and India's public-health system is set up to treat them quickly, freely, and confidentially when women are able to reach it.

• Chlamydia (Chlamydia trachomatis) — the most common bacterial STI worldwide and a major silent cause of infertility in Indian women.
• Gonorrhoea (Neisseria gonorrhoeae) — bacterial; often appears with chlamydia and is treated together.
• Trichomoniasis (Trichomonas vaginalis) — a parasitic infection causing frothy, foul-smelling discharge; very treatable.
• Genital herpes (HSV-1 and HSV-2) — viral, lifelong, manageable rather than curable; recurrences are controllable with medication.
• Syphilis (Treponema pallidum) — bacterial, fully curable when caught early; universal screening in pregnancy under PMSMA.
• HIV (human immunodeficiency virus) — viral, lifelong, but a chronic manageable condition on free ART under NACO.
• Hepatitis B — viral, sexually transmissible, vaccine-preventable; free under the Universal Immunization Programme for newborns and for at-risk adults.
• Human papillomavirus (HPV) — viral, often self-clearing, the cause of genital warts and (in persistent high-risk strains) cervical cancer; covered in detail in hpv-types-symptoms-treatment-india.

• Chlamydia is often completely symptomless in women. When symptoms do appear they include a slight increase in vaginal discharge, mild burning while urinating, and pain during sex. Untreated chlamydia is the leading preventable cause of pelvic inflammatory disease, tubal infertility, and ectopic pregnancy in Indian women. Diagnosed by a PCR test on a vaginal or cervical swab (roughly 800 to 2,500 rupees in private labs; free at NACO DSCs). Treated with a single 1 gram dose of azithromycin, or doxycycline 100 mg twice daily for 7 days — total cost of medicine around 50 to 200 rupees.
• Gonorrhoea more often makes itself known: a thicker yellow or green pus-like discharge, burning urination, and sometimes a sore throat or rectal symptoms depending on the route of exposure. Untreated, it joins chlamydia as a major cause of PID and infertility. Diagnosis is by PCR or culture (roughly 500 to 2,500 rupees). The current Indian guideline is a single intramuscular injection of ceftriaxone 500 mg plus a 1 gram oral dose of azithromycin (around 500 to 1,500 rupees together).
• Trichomoniasis is a parasitic infection that announces itself loudly — a frothy, yellow-green vaginal discharge with a noticeable smell, often with vulvar itching and irritation. Diagnosis is straightforward on a wet-mount slide or NAAT (roughly 300 to 1,500 rupees). Treatment is a single 2 gram dose of metronidazole, or 500 mg twice daily for 7 days — around 50 to 300 rupees of medicine.
• For all three: partners should be tested and treated at the same time, even if they have no symptoms, otherwise re-infection is almost guaranteed. Sex is avoided until both partners have completed treatment.
• All three of these infections are confirmed cured by clinical resolution and, in many Indian clinics, a follow-up test of cure 3 to 4 weeks after treatment finishes.

Genital herpes is caused by herpes simplex virus types 1 or 2. Type 2 has historically been the genital strain, but type 1 (the cold-sore virus) now causes a large and growing share of first-episode genital herpes, transmitted through oral sex.

A first outbreak can be intense — clusters of small, painful blisters on the vulva, around the vaginal opening, or on the cervix, often with low fever, body ache, and swollen groin lymph nodes. The blisters break, form shallow ulcers, and heal over 2 to 3 weeks. Later outbreaks are usually shorter, milder, and sometimes preceded by a tingling or burning warning.

Diagnosis is by PCR swab of a fresh ulcer (the most accurate test) or, between outbreaks, by an HSV antibody blood test. Both tests are available in most Indian private labs at moderate cost; the PCR is the more useful one during an active episode.

Treatment does not eradicate the virus — herpes is lifelong — but acyclovir 400 mg three times a day for 7 to 10 days cuts the length and severity of an outbreak dramatically, especially when started in the first 24 to 48 hours. For women with frequent recurrences (six or more a year, for example), daily suppressive therapy at 400 mg twice a day reduces both the number of outbreaks and the risk of transmitting the virus to a partner.

A genital herpes diagnosis is not a verdict on the relationship or on the patient's character. The virus is extremely common, often carried silently for years, and entirely compatible with a long-term sexual relationship when both partners understand the basics. Pregnancy planning is straightforward — most women with herpes deliver vaginally; antiviral medication is given in the final weeks to reduce the very small risk of passing the virus on at birth, and a Caesarean is recommended only if active blisters are present at the time of labour.

• Syphilis is caused by Treponema pallidum and is fully curable when caught early. It moves through stages — a painless ulcer (chancre) at the site of infection in the primary stage, then a body-wide rash and flu-like illness in the secondary stage, then a silent latent stage that can last years, and finally a tertiary stage that damages heart, brain, and bone if untreated.
• Screening is by a VDRL or RPR blood test, with confirmation by a TPHA or FTA-Abs test. Both are widely available in Indian private labs (roughly 200 to 800 rupees together) and free at NACO ICTC and DSC centres.
• Under the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA), every pregnant woman in India is offered free syphilis screening at her first antenatal visit, along with HIV and hepatitis B. This is one of India's most successful public-health interventions and has driven a steep fall in congenital syphilis.
• Treatment is a single intramuscular injection of benzathine penicillin G 2.4 million units for primary and secondary syphilis, with three weekly doses for late or unknown-duration infection. The medicine itself costs roughly 200 to 500 rupees and is free at government centres. A short course of antihistamines and observation manages the rare Jarisch-Herxheimer reaction that can follow the first dose.
• Partners need testing and treatment, and follow-up VDRL titres are tracked at 6 and 12 months to confirm cure.

• HIV (human immunodeficiency virus) attacks the immune system. Early infection often passes for a brief flu-like illness in the first few weeks. Then comes a long asymptomatic period — sometimes a decade or more — during which the virus quietly damages immune cells. Without treatment, this leads to AIDS, defined by very low CD4 counts and the opportunistic infections the weakened immune system can no longer fight.
• Diagnosis is by a simple HIV antibody rapid test, with a confirmatory ELISA or Western blot. Rapid tests are free at every NACO ICTC across India and at private clinics for roughly 100 to 500 rupees.
• Treatment has changed beyond recognition in the last two decades. Lifelong antiretroviral therapy (ART) — a single daily tablet for most patients — keeps the virus suppressed to undetectable levels, restores immunity, and gives a near-normal life expectancy. ART is free at NACO ART Centres nationwide and provided lifelong without cost to Indian patients.
• Pregnancy is safe and supported. Under NACO's Prevention of Mother-to-Child Transmission (PMTCT) programme, every pregnant woman is offered free HIV testing, and women who test positive receive free ART throughout pregnancy and delivery. With proper treatment, the risk of passing HIV to the baby falls to under 2 percent.
• PrEP (pre-exposure prophylaxis) — a daily tenofovir-based tablet taken before exposure — is highly effective at preventing HIV in people at higher risk. In India it costs roughly 2,000 to 5,000 rupees per month privately and is available free through select NACO targeted-intervention programmes.
• PEP (post-exposure prophylaxis) — a 28-day course of ART taken after a possible exposure — must be started within 72 hours, ideally within 24. It is free at all government hospitals and roughly 2,000 to 5,000 rupees privately. If you think you have had a high-risk exposure (condom failure, sexual assault, needle injury), go to the nearest district hospital today, not tomorrow.
• U equals U — undetectable equals untransmittable — is the most important sentence in modern HIV care. A person whose viral load is suppressed on ART cannot pass HIV on through sex. This is now established medicine, not optimism.

• 1,100-plus Designated STI Clinics (DSCs) attached to medical colleges and district hospitals, providing free syndromic management, partner notification support, and follow-up.
• 50-plus District-Level Hospitals with full STI service kits — laboratory testing, prescribed treatment, condoms, and counselling all at no cost.
• 65,000-plus Integrated Counselling and Testing Centres (ICTCs) — by far the largest network — offering free, walk-in HIV testing with same-day rapid results and onward referral for any other STI work-up needed.
• Free condoms (the Nirodh brand) at most government hospitals, primary health centres, and outreach camps.
• Confidentiality is part of the legal mandate. NACO staff are trained never to disclose results to family members, employers, or partners without the patient's consent.
• Care is offered regardless of age, marital status, or whether the patient brings a partner. A young unmarried woman walking into a NACO DSC is legally and ethically entitled to the same care as anyone else.
• Find your nearest DSC, ICTC, or ART Centre on naco.gov.in or via the NACO Helpline on 1097 (toll-free, confidential, 24 hours).

• HIV — at least once in adult life, and annually if you have multiple sexual partners, a new partner, or a partner whose status you do not know.
• Syphilis — at least once, annually if higher risk, and always at the first antenatal visit in every pregnancy under PMSMA.
• Chlamydia and gonorrhoea — annually for sexually active women under 25, and annually at any age for women with a new partner, multiple partners, or symptoms.
• Hepatitis B — once in adult life with an HBsAg test; annually if you or your partner are at higher risk. The hepatitis B vaccine is free for newborns under the Universal Immunization Programme and recommended for unvaccinated adults.
• HPV — combined with Pap smear screening from age 30 onwards, repeated every 5 years for HPV DNA testing or every 3 years for Pap alone. See hpv-types-symptoms-treatment-india for the full schedule.
• Any time you notice new symptoms — unusual discharge, sores, bleeding after sex, pelvic pain — get tested promptly rather than waiting for a 'better time'.
• Bring this schedule to your gynaecologist at your next visit. A 5-minute conversation usually clarifies which tests you genuinely need this year and which can wait.

• Male condoms remain the single most effective barrier against most STIs, including HIV. Nirodh-brand condoms are free at every government health facility; branded condoms cost roughly 100 to 300 rupees for a 10-pack at chemists.
• Female condoms (internal condoms) protect against STIs and pregnancy and are entirely under the user's control. Availability in India is currently limited; some NACO programmes and select urban pharmacies stock them.
• Dental dams — thin latex sheets used as a barrier during oral sex on a vulva or anus — are uncommon in Indian pharmacies. A condom cut open lengthwise serves the same purpose if a dam is not available.
• Mutual monogamy with a tested partner is itself a strong protection, provided both partners' STI status is genuinely known and both stay monogamous.
• Limiting the number of new partners and asking about partner history, while imperfect, lowers risk in real-world terms.
• PrEP — daily tenofovir/emtricitabine for adults at higher HIV risk — is roughly 2,000 to 5,000 rupees per month in private practice and free in select NACO targeted-intervention programmes.
• HPV vaccination (Cervavac or Gardasil 9) and hepatitis B vaccination both prevent specific viral STIs and are worth completing. See hpv-types-symptoms-treatment-india for the HPV vaccine in detail.
• Reducing alcohol around new partners, never sharing needles, and avoiding douching (which disturbs vaginal defences and increases STI risk) round out the practical list.

• At the first antenatal visit, every pregnant woman in India is offered HIV, syphilis, and hepatitis B testing free under PMSMA. These three tests are non-negotiable parts of safe antenatal care, regardless of perceived risk.
• Untreated maternal STIs can cause miscarriage, stillbirth, preterm birth, low birthweight, eye infection in the newborn (chlamydia and gonorrhoea), congenital syphilis, neonatal herpes, vertical transmission of HIV, and chronic hepatitis B in the baby.
• Most STI treatments are safe in pregnancy. Penicillin treats syphilis fully and is the only proven option in pregnancy. Ceftriaxone and azithromycin are safe for gonorrhoea and chlamydia. Metronidazole is safe for trichomoniasis after the first trimester (and even in the first trimester when the benefit clearly outweighs the small theoretical risk). Acyclovir is safe for herpes. ART is safe and recommended for HIV. Hepatitis B immunoglobulin and the birth-dose vaccine prevent transmission to the newborn.
• Partners of pregnant women diagnosed with an STI need testing and treatment too, otherwise reinfection in pregnancy is common.
• Caesarean section is not automatically required for STIs. The clearest indication is active genital herpes lesions at the time of labour. Otherwise, vaginal delivery is usually safe under the obstetrician's plan.

• Confidentiality is a legal and ethical obligation for every Indian doctor and every NACO clinic. STI test results, including HIV, cannot be disclosed to family, employer, or partner without the patient's informed consent.
• The HIV and AIDS (Prevention and Control) Act, 2017 made HIV-related discrimination — in healthcare, employment, education, insurance, or housing — a punishable offence. Other STIs sit under general medical confidentiality but the principle is identical.
• Partner notification is handled through counselling rather than coercion. A trained counsellor helps the patient think through who needs to be informed (typically sexual partners from the last 60 to 90 days, depending on the infection), and offers to inform partners on the patient's behalf with no name attached. The patient is always in control of the conversation.
• The Indian stigma around STIs is heavy. The cultural script that 'good women don't get STIs' delays diagnosis by months or years. Married women infected by their husbands are often the most reluctant to test because the diagnosis confronts an uncomfortable truth in the marriage. Premarital silence around sex keeps young women out of the screening conversation altogether.
• Naming the stigma helps to defuse it. STIs are infections, not character verdicts; testing is medicine, not confession; and treatment is usually quick, free, and confidential under the NACO system. The bravest and most caring thing many women do for their families is to walk into a clinic when something feels wrong.
• For mental-health support around an STI diagnosis or the conversations that follow, iCall on 9152987821 offers free, confidential counselling in multiple Indian languages.

• Myth: STIs are a punishment for promiscuity. Fact: STIs are bacterial, viral, or parasitic infections, no different morally from a cold or a urinary tract infection. They are extremely common and entirely treatable.
• Myth: A married woman in a faithful relationship cannot get an STI. Fact: She can, if her partner brings an infection from before the marriage or from outside it. Many Indian women are diagnosed in exactly this situation.
• Myth: Birth control pills prevent STIs. Fact: Hormonal contraception prevents pregnancy, not infection. Only barrier methods (condoms, dental dams) reduce STI transmission.
• Myth: STIs clear up on their own if you wait. Fact: Most bacterial and parasitic STIs do not clear without treatment, and untreated chlamydia, gonorrhoea, or syphilis can cause infertility, pelvic damage, or systemic illness years later.
• Myth: One round of antibiotics cures every STI. Fact: Antibiotics cure bacterial STIs (chlamydia, gonorrhoea, syphilis) and the parasitic trichomoniasis. They do not cure viral STIs — HIV, herpes, hepatitis B, HPV — which are managed differently.
• Myth: An STI diagnosis will end my marriage or career. Fact: Indian law and NACO policy protect confidentiality strictly. The diagnosis is medical information, not public information, and almost all STIs are very manageable with treatment.